Schedule 13G ownership disclosure
Monte Rosa Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 61225M102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Baker Bros. Advisors LP
Shares: 4,345,736.00 · Class: 6.7%
- Baker Bros. Advisors (GP) LLC
Shares: 4,345,736.00 · Class: 6.7%
- Julian C. Baker
Shares: 4,345,736.00 · Class: 6.7%
- Felix J. Baker
Shares: 4,345,736.00 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-016412
- Form type
- SCHEDULE 13G/A
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership